{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:26:07Z","timestamp":1781151967367,"version":"3.54.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[1997,9]]},"abstract":"<jats:p>\n            <jats:italic>Background and Purpose<\/jats:italic>\n            [\n            <jats:sup>123<\/jats:sup>\n            I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO\n            <jats:sub>2<\/jats:sub>\n            ), and cerebral metabolic rate of glucose (CMRGlc) studied by positron emission tomography in the chronic stage of ischemic stroke.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods<\/jats:italic>\n            Five patients (male; mean age, 63.2\u00b16.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO\n            <jats:sub>2<\/jats:sub>\n            , and CMRGlc obtained by positron emission tomography in the same perfusion areas both visually and quantitatively.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Results<\/jats:italic>\n            In the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO\n            <jats:sub>2<\/jats:sub>\n            , and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO\n            <jats:sub>2<\/jats:sub>\n            values (\n            <jats:italic>r<\/jats:italic>\n            =.45,\n            <jats:italic>P<\/jats:italic>\n            &lt;.05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            The use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.\n          <\/jats:p>","DOI":"10.1161\/01.str.28.9.1776","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:08:03Z","timestamp":1308341283000},"page":"1776-1782","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Assessment of Benzodiazepine Receptors Using Iodine-123\u2013Labeled Iomazenil Single-Photon Emission Computed Tomography in Patients With Ischemic Cerebrovascular Disease"],"prefix":"10.1161","volume":"28","author":[{"given":"Yun","family":"Dong","sequence":"first","affiliation":[{"name":"From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Fukuyama","sequence":"additional","affiliation":[{"name":"From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Nabatame","sequence":"additional","affiliation":[{"name":"From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shibasaki","sequence":"additional","affiliation":[{"name":"From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Yonekura","sequence":"additional","affiliation":[{"name":"From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00232579"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/290514a0"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90060-X"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)90276-7"},{"key":"e_1_3_2_5_2","first-page":"1593","volume":"27","year":"1986","unstructured":"Shinotoh H, Yamasaki T, Inoue O, Itoh T, Suzuki K, Hashimoto K, Tateno Y, Ikehira H. Visualization of specific binding sites of benzodiazepine in human brain. J Nucl Med. 1986;27:1593-1599.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0883-2897(89)90158-X"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90218-3"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(85)90080-9"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.24.12.8248987"},{"key":"e_1_3_2_10_2","first-page":"1007","volume":"31","year":"1990","unstructured":"Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, Hunkeler W, Bonetti EP, Pieri L, Richards JG, Schubiger PA. In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med. 1990;31:1007-1014.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90182-Q"},{"key":"e_1_3_2_12_2","first-page":"249","volume":"13","year":"1992","unstructured":"Cordes M, Henkes H, Ferstl F, Schmitz B, Hierholzer J, Schmidt D, Felix R. Evaluation of focal epilepsy: a SPECT scanning comparison of 123-I-iomazenil versus HM-PAO. AJNR Am J Neuroradiol. 1992;13:249-253.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00950756"},{"key":"e_1_3_2_14_2","first-page":"95","volume":"50","year":"1990","unstructured":"van Huffelen AC, van Isselt JW, van Veelen CWM, van Rijk PP, van Bentum AME, Dive D, Maquet P, Franck G, Velis DN, van Emde Boas W, Debets RMC. Identification of the side of epileptic focus with 123I-iomazenil SPECT: a comparison with 18FDG-PET and ictal EEG findings in patients with medically intractable complex partial seizures. Acta Neurochir Suppl Wien. 1990;50:95-99.","journal-title":"Acta Neurochir Suppl Wien"},{"key":"e_1_3_2_15_2","first-page":"2154","volume":"36","year":"1995","unstructured":"Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami I, Ogawa T, Fugita H, Noguchi K, Kanno I, Miura S, Murakami M, Iida H, Miura Y, Uemura K. Evaluation of cerebral infarction with iodine-123-iomazenil SPECT. J Nucl Med. 1995;36:2154-2161.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_16_2","first-page":"877","volume":"29","year":"1988","unstructured":"Mukai T, Senda M, Yonekura Y, Tamaki N, Yamamoto K, Nishizawa S, Saji H, Fujita T, Konishi J, Torizaka K, Inoue S, Ohgushi A, Kumamoto M. System, design and performance of a newly developed high resolution PET scanner using double wobbling mode. J Nucl Med.. 1988;29:877. Abstract.","journal-title":"J Nucl Med."},{"key":"e_1_3_2_17_2","unstructured":"Endo M Fukuda H Suhara T Matsumoto T Iimura T Yamasaki T Tateno Y Nohara N Ohgushi A Kumamoto M Inoue S. Design and performance of PCT-3600W (15 slice type): a whole-body positron emission tomography. J Nucl Med. 1991;32(suppl):1061."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198012000-00001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1983.67"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410060502"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1985.24"},{"key":"e_1_3_2_22_2","first-page":"165","volume":"2","year":"1995","unstructured":"Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapping. 1995;2:165-189.","journal-title":"Hum Brain Mapping"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.21.10.2219203"},{"key":"e_1_3_2_24_2","unstructured":"Krestchmann HJ Weinrich W. Neuroanatomy and Cranial Computed Tomography. New York NY: Thiem Medical Publishers Inc; 1986:70-74."},{"key":"e_1_3_2_25_2","first-page":"1754","volume":"32","year":"1991","unstructured":"Innis RB, Al-Tikriti MS, Zoghbi SS, Baldwin RM, Sybirska EH, Laruelle MA, Malison RT, Seibyl JP, Zimmermann RC, Johnson EW, Smith EO, Charney DS, Heninger GR, Woods SW, Hoffer PB. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med. 1991;32:1754-1761.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_26_2","first-page":"228","volume":"35","year":"1994","unstructured":"Abi Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea Ponce Y, Bremner JD, Hyde TM, Charney DS, Hoffer PB, Innis RB. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. J Nucl Med. 1994;35:228-238.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_27_2","first-page":"87","volume":"32","year":"1995","unstructured":"Yonekura Y, Nishizawa S, Tanaka F, Ishizu K, Okazawa H, Fujita T, Konishi J, Torizuka K. Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT. Kaku Igaku. 1995;32:87-97.","journal-title":"Kaku Igaku"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.17.5.3532434"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1987.12"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1981.54.6.0773"},{"key":"e_1_3_2_31_2","unstructured":"Graham DI. Hypoxia and vascular disorders. In: Adams JH Duchen LW eds. Greenfield\u2019s Neuropathology. London England: Edward Arnold; 1992: 153-268."},{"key":"e_1_3_2_32_2","unstructured":"Kogure K Kato H. Neurochemistry of stroke. In: Barnett HJM Mohr JP Stein BM Yatsu FM eds. Stroke: Pathophysiology Diagnosis and Management. New York NY: Churchill Livingstone Inc; 1992:69-95."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(82)90833-2"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110509"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.4.420"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00340846"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199506000-00004"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.28.9.1776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:29:19Z","timestamp":1715552959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.28.9.1776"}},"subtitle":["A Comparison With PET Study"],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1161\/01.STR.28.9.1776"],"URL":"https:\/\/doi.org\/10.1161\/01.str.28.9.1776","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]},"assertion":[{"value":"1996-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}